Last update 05 Sep 2026

Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
PZ 01, PZ-01, PZ01
Target
CD19
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
CD19 positive B-Cell LymphomaCD19-positive B-cell acute lymphoblastic leukemiaRefractory B Acute Lymphoblastic Leukemia
Originator Organization
Pinze Lifetechnology Co. Ltd.
Active Organization-
Inactive Organization
Pinze Lifetechnology Co. Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.)
NCT03281551
/ Unknown statusPhase 1
Study of Anti-CD19 Chimeric Antigen Receptor T Cells（PZ01） for Relapsed/ Refractory B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma
100 Clinical Results associated with Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.)
Login to view more data
100 Deals associated with Anti-CD19 CAR-T cell therapy(Pinze Lifetechnology Co. Ltd.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD19 positive B-Cell LymphomaPhase 1
China
Pinze Lifetechnology Co. Ltd.
01 Oct 2017
CD19-positive B-cell acute lymphoblastic leukemiaPhase 1
China
Pinze Lifetechnology Co. Ltd.
01 Oct 2017
Refractory B Acute Lymphoblastic LeukemiaPhase 1
China
Pinze Lifetechnology Co. Ltd.
01 Oct 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free